Meesmann corneal dystrophy

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Meesmann corneal dystrophy
Synonyms Meesmann epithelial corneal dystrophy, Meesmann dystrophy
Pronounce N/A
Specialty N/A
Symptoms Corneal epithelium microcysts, vision disturbances
Complications Corneal erosion, photophobia
Onset Early childhood
Duration Lifelong
Types N/A
Causes Mutations in KRT3 or KRT12 genes
Risks Genetic predisposition
Diagnosis Slit-lamp examination, genetic testing
Differential diagnosis Other corneal dystrophies
Prevention N/A
Treatment Lubricating eye drops, contact lenses, keratoplasty
Medication N/A
Prognosis Generally good with management
Frequency Rare
Deaths None directly attributable


Autosomal dominant inheritance pattern

Meesmann corneal dystrophy (ICD-10: H18.5) is a rare form of corneal dystrophy, a group of genetic, often progressive, eye disorders characterized by the accumulation of abnormal material in the cornea. The cornea is the clear, dome-shaped surface that covers the front of the eye. Meesmann corneal dystrophy is caused by mutations in the KRT3 or KRT12 gene. These genes provide instructions for making proteins that are part of intermediate filaments, tough, resilient fibers that provide support and strength to cells. The KRT3 and KRT12 genes are specifically involved in the production of keratins, a type of intermediate filament protein, in corneal epithelial cells. Mutations in these genes alter the structure and function of these proteins, leading to the formation of abnormal, blister-like lesions in the cornea. Symptoms of Meesmann corneal dystrophy typically appear in early childhood and may include photophobia (light sensitivity), a gritty sensation in the eyes, and mild visual impairment. However, many affected individuals are asymptomatic and the condition is often discovered during a routine eye examination. Treatment for Meesmann corneal dystrophy is typically supportive and may include the use of lubricating eye drops or ointments to relieve discomfort. In severe cases, a corneal transplant may be necessary.

See also[edit]

References[edit]

External links[edit]






NIH genetic and rare disease info[edit]

Meesmann corneal dystrophy is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.